STRS Ohio’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

STRS Ohio’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,100	Closed	-$6K	–	2483
2021 Q1	$6K	Hold	1,100	–	–	﹤0.01%	2144
2020 Q4	$5K	Hold	1,100	–	–	﹤0.01%	2137
2020 Q3	$4K	Hold	1,100	–	–	﹤0.01%	2161
2020 Q2	$31K	Hold	1,100	–	–	﹤0.01%	1981
2020 Q1	$23K	Hold	1,100	–	–	﹤0.01%	1891
2019 Q4	$21K	Buy	+1,100	New	+$15.6K	﹤0.01%	1975

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's STSA Position: Q2 2021 in Review

STRS Ohio sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2021, closing a stake of 1,100 shares — an estimated $6K sold.

STRS Ohio first reported a position in STSA in Q4 2019 and held it in 6 quarters. The position peaked at $31K in Q2 2020. 60 funds tracked by Wall St. Rank hold STSA as of Q2 2021.

STRS Ohio reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 1,100 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $6K.
STRS Ohio first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
STRS Ohio's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $31K in Q2 2020.
60 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.